IER5 and acute myeloid leukemia: U937 cells were transfected with IER5 shRNA-#1 or -#2, and the effect of IER5 knock-down on AML cell proliferation was assessed over 72 h of culture, starting from day 3 day post-transfection (Fig. 3).